Skip to main content
. Author manuscript; available in PMC: 2010 Nov 23.
Published in final edited form as: Vaccine. 2009 Sep 26;27(50):7087–7095. doi: 10.1016/j.vaccine.2009.09.059

Figure 7. Comparison of co-immunization of EP HIV-1090 DNA vaccine and EP-1043 protein vaccine with EP HIV-1090 vaccine alone.

Figure 7

The DNA plasmid was administered to HLA-A2.1 transgenic C57BL/6 X BALB/c F1 mice alone or in combination with EP-1043 protein vaccine. Immune responses were measured using purified CD8 T-lymphocytes in an ELISPOT with IFN-γ production as the readout. Data are presented for each of the epitopes as the mean number of Spot Forming Cells (SFC) per million CD8+ T-lymphocytes.